Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 249

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 249
---
 of NLS Common Shares, in order to satisfy the applicable Nasdaq initial listing requirements for the combined company following the Merger and Nasdaq shall have approved such listing of NLS Common Shares post such stock split; •NLS shall have obtained the all the Israeli related exemptions and consents; •except as agreed upon by the parties, all terms and conditions of the CVR Agreement shall remain in full force and effect; •applicable tax ruling shall have been approved by the Israeli Tax Authorities; •except as agreed upon by the parties, all terms and conditions of the Exchange Agreement shall remain in full force and effect; and •NLS shall have submitted the required Nasdaq notifications in accordance with Nasdaq rules and Nasdaq shall not have objected to such notifications on or prior to the Closing Date, as well as the notifications to any Swiss regulator as are required for the consummation of the Merger and issuance of the Merger Consideration. Unless waived by NLS, the obligations of NLS and Merger Sub to consummate the Merger are subject to the satisfaction of the following additional conditions, in addition to customary certificates and other closing deliverables: •the representations and warranties of Kadimastem shall be true and correct as of the Closing (subject to Material Adverse Effect); •Kadimastem shall have performed in all material respects its obligations and complied in all material respects with its covenants and agreements under the Merger Agreement required to be performed or complied with on or prior to the date of the Closing; •the absence of any Material Adverse Effect with respect to Kadimastem, taken as a whole, since the date of the Merger Agreement which is continuing and uncured; •the D&O Run Off Policy shall be in effect; •a favorable tax ruling from the Federal Tax Authority shall have been obtained confirming that the stamp duty tax is triggered by this Agreement; •Kadimastem shall have in gross funds (including cash in any of its bank accounts) an amount equal to at least $3,500,000, subject to adjustment based on the proceeds received by NLS from certain parties in connection with its financing transactions undertaken after the execution of the Merger Agreement; 123 •Kadimastem shall have received tax rulings in form and substance reasonably acceptable to NLS; and •Kadimastem shall have provided evidence reasonably satisfactory to NLS that Kadimastem Ordinary Shares shall have been delisted from the TASE effective as of the Effective Time